Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – What’s Next?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $14.53, but opened at $13.46. Anbio Biotechnology shares last traded at $14.10, with a volume of 15,742 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Anbio Biotechnology Stock Down 9.9%

The firm’s 50-day simple moving average is $24.04.

Anbio Biotechnology (NASDAQ:NNNN) last issued its earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share (EPS) for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.